Clinical trial

Evaluating Optimal Timing of Endocrine Therapy and Radiation Therapy in Early-stage Breast Cancer (REaCT-RETT)

NCT03948568

Study summary

ClinicalTrials.gov

Evaluating Optimal Timing of Endocrine Therapy and Radiation Therapy in Early-stage Breast Cancer (REaCT-RETT)

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

COMBINATION_PRODUCT · Unmapped registry intervention Endocrine Therapy and Radiotherapy Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-09-17

PhasePHASE4

Conditions

Early-stage Breast Cancerunresolved

Interventions

Endocrine Therapy and RadiotherapyCOMBINATION_PRODUCT

Sponsors & collaborators

Ottawa Hospital Research Institutelead sponsor

Mapped research locations

OttawaOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03948568 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.